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We wish to understand how cell-cell signaling in devel-2 Neural Development Group
oping embryos coordinates growth, differentiation, andDivision of Cell and Developmental Biology
morphogenesis. Fibroblast growth factors (FGFs) com-School of Life Sciences
prise a major family of signaling molecules which areUniversity of Dundee
used in many different developmental contexts. StudiesDow Street
in mice, Xenopus, Drosophila, and C. elegans demon-Dundee DD1 5EH
strate that FGF signaling is mediated via tyrosine kinaseUnited Kingdom
receptors (FGFRs) that can act through a number of3 Cancer Research UK
transduction pathways, including the highly conservedMolecular Pharmacology Unit
Ras-ERK mitogen-activated protein kinase (MAPK) sig-Biomedical Research Centre
naling cascade [1–4]. Here we focus on FGF signalingLevel 5, Ninewells Hospital
in neural induction and limb bud outgrowth in chickDundee DD1 9SY
embryos, where downstream pathways that mediateUnited Kingdom
these events are not known.
Recent work has revealed that FGF signaling is nega-
tively regulated by complex intracellular systems which
Summary include Sprouty, Sef, Spred, and FRS2 [5–11]. Further-
more, expression of Sprouty and Sef is induced by acti-
Background: The importance of endogenous antago- vation of the MAP kinase cascade itself, demonstrating
nists in intracellular signal transduction pathways is be- that these operate in negative feedback loops [7, 8, 12].
coming increasingly recognized. There is evidence in Sef coimmunoprecipitates with FGFR [8] while Sprouty2
cultured mammalian cells that Pyst1/MKP3, a dual spec- prevents activation of raf [13] in some contexts (also
ificity protein phosphatase, specifically binds to and in- see [14]), indicating that there may be multiple points
activates ERK1/2 mitogen-activated protein kinases of regulation at different levels within the FGF signaling
(MAPKs). High-level Pyst1/Mkp3 expression has re- pathway.
cently been found at many sites of known FGF signaling Biochemical assays and studies in cultured mamma-
in mouse embryos, but the significance of this associa- lian cells have identified phosphatases that specifically
tion and its function are not known. act on the ERK1/2 MAP kinases [15]. These include the
Results: We have cloned chicken Pyst1/Mkp3 and closely related enzymes Pyst1/MKP3, Pyst2/MKPX, and
show that high-level expression in neural plate corre- Pyst3/MKP4, which constitute a distinct subfamily of
lates with active MAPK. We show that FGF signaling dual specificity MAP kinase phosphatases (MKPs).
regulates Pyst1 expression in developing neural plate Pyst1/MKP3 binds selectively to ERK2, which results in
and limb bud by ablating and/or transplanting tissue catalytic activation of the phosphatase [16, 17], and
sources of FGFs and by applying FGF protein or a spe- expression of Pyst1 in mammalian cells specifically
cific FGFR inhibitor (SU5402). We further show by blocks activation and nuclear translocation of ERK2 [16,
applying a specific MAP kinase kinase inhibitor 18]. All of these observations strongly suggest that Pyst1
(PD184352) that Pyst1 expression is regulated via the acts as an intracellular brake to signal transduction
MAPK cascade. Overexpression of Pyst1 in chick em- through the Ras/MAPK pathway in mammalian cells.
bryos reduces levels of activated MAPK in neural plate However, nothing is known about the regulation of Pyst1
and alters its morphology and retards limb bud out- expression or its relationship with MAPK signaling in
growth. vivo, and direct evidence for a physiological role for
Conclusions: Pyst1 is an inducible antagonist of FGF Pyst1 in the regulation of MAPK signaling during verte-
signaling in embryos and acts in a negative feedback brate development or in adult tissues is currently
loop to regulate the activity of MAPK. Our results dem- lacking.
onstrate both the importance of MAPK signaling in neu- Recently we reported that Pyst1/MKP3 is strikingly
ral induction and limb bud outgrowth and the critical role expressed in many sites of known FGF signaling in
mouse embryos [19]. This association suggests that
Pyst1 is involved in the regulation of FGF signaling dur-
*Correspondence: stephen.keyse@cancer.org.uk (S.M.K.); k.g.storey@ ing vertebrate development. In order to explore the func-
dundee.ac.uk (K.S.); c.a.tickle@dundee.ac.uk (C.T.)
tional role of Pyst1 in the embryo, we isolated the chick4 These authors contributed equally to this work.
homolog of Pyst1 and investigated whether expression5 Present address: School of Biological Sciences, University of East
Anglia, Norwich NR4 7TJ, United Kingdom. of this gene in the developing neural plate and limb buds
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Figure 1. Expression Pattern of Chick Pyst1
(A) Pyst1 expression at Eyal-Giladi stage X.
(A) Transverse section (TS) showing Pyst1
expression in epiblast layer. (B-D) Pyst1 ex-
pression from HH3 to HH4 is gradually re-
stricted to the neural plate and is absent in
primitive streak (ps). (D and D″) TS showing
Pyst1 in neural plate and not in primitive
streak. (E) Activated MAPK is detected in the
neural plate and primitive streak. (E and E″)
TS. Brown staining in periphery is due to trap-
ping of reagents by yolk and not expression
in the extra-embryonic epiblast (see Supple-
mental Figure S1B). (F) Pyst1 expression in
the presumptive forelimb (fl) and hindlimb (hl),
as well as midbrain-hindbrain isthmus region
and somites at HH15. (G) Double in situ hy-
bridization showing mesenchymal expres-
sion of Pyst1 (blue) and ectodermal expres-
sion of Fgf8 (magenta) in HH20 limb buds.
(H and H) Restriction of Pyst1 to distal limb
mesoderm of older limb bud at stage HH24.
(H) TS of limb bud in (H), showing Pyst1 ex-
pression absent in dorsal and ventral ecto-
derm (white arrowheads) and apical ectoder-
mal ridge (black arrowhead). D, dorsal; Di,
distal; Pr, proximal; V, ventral.
depends on FGF-mediated activation of MAPK. Finally, and 4 [1], Pyst1 is expressed more or less throughout
the mesoderm (Figure 1G). As limb buds elongate, Pyst1we tested the developmental consequences of overex-
pressing Pyst1 in these regions. expression becomes confined to distal limb mesoderm
beneath the apical ridge which continues to express
Fgf8 (Figures 1H and 1H).Results
This tight correlation between Pyst1 expression and
tissue sources of FGF signaling led us to test whetherPyst1/MKP3 from chickens is highly similar to homolo-
gous proteins in human, mouse, rat, and frog (see Supple- these cell populations induce and/or maintain Pyst1 ex-
pression in neural plate and limb bud mesoderm, re-mental Figure S1A available with this article online at
http://www.current-biology.com/content/supplemental). spectively, and whether FGF signaling is involved.
To determine whether the node can induce Pyst1 ex-As in mouse [19], Pyst1 expression in chick embryos is
associated with many sites of FGF signaling. Here we pression, we used a well-established neural induction
assay in which we transplanted HH3 nodes into hostfocus on FGF signaling from Hensen’s node, which initi-
ates neural development [20–22], and from limb apical HH3 extra-embryonic epiblast [20, 29]. In nearly all
cases, ectopic Pyst1 expression is induced within 4 hrectodermal ridge, which mediates bud outgrowth, ac-
companied by progressive formation of structures along in epiblast overlying the donor node (20/21 cases; Fig-
ures 2A and 2B). Quail donor nodes were used to confirmthe long axis of the limb [23]. Pyst1 expression is first
detected in the epiblast layer of pre-streak Eyal-Giladi Pyst1 induction in chick hosts (7/8 cases; Supplemental
Figures S2A, S2A, and S2B). In contrast, grafts of HH3stage X embryos (Figures 1A and 1A) and becomes
gradually restricted to neural plate in a pattern that re- posterior primitive streak which is not normally flanked
by Pyst1-expressing cells only occasionally elicit ex-sembles the FGF-inducible preneural gene Sox3 [21].
By Hamilton and Hamburger stages (HH) 4, Pyst1 is pression (2/9 cases; data not shown). These findings
indicate that the node is a specific source of Pyst1-expressed in neural plate close to the node (tip of primi-
tive streak) (Figures 1B–1D, 1D, and 1D″), which ex- inducing signals and place Pyst1 in the group of preneu-
ral genes expressed as an early response to neural in-presses FGF2 and Fgfs3, 4, and 8 [21, 24–26]. Many cells
responding to FGF signaling in early embryos signal via ducing signals (see [21]).
To test whether FGF signals are sufficient to initiatethe Ras/MAPK cascade (e.g., [7, 27]) and, consistent
with this, the activated form of MAPK is detected in the Pyst1 expression in extra-embryonic epiblast, beads
soaked in FGFs 4, 8, or 7 were grafted to this region.primitive streak and overlaps with Pyst1 in the early
neural plate (Figures 1E, 1E, and 1E″; also see Supple- FGF4 beads induce Pyst1 within 1 hr (8/8 cases, 1 hr;
15/19 cases, 2 hr), and this gene is strongly expressedmental Figure S1B).
Pyst1 is expressed in presumptive limb-forming re- after 4 hr (33/35 cases; Figure 2C), while FGF8, a less
potent mitogen than FGF4 [30], elicits ectopic Pyst1gions in chick embryos (Figure 1F) at a time when Fgf8 is
expressed in neighboring intermediate mesoderm [28]. expression after 2 hr (4/8 cases; Figure 2D). In all cases
(n  4), control PBS beads do not induce Pyst1 (FigureThen, as limb buds form with an apical ridge at the tip
which expresses several different Fgfs, including Fgf8 2E). In contrast, FGF7, which has a restricted FGFR
FGF Signaling and Pyst1/MKP3
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Figure 2. Pyst1 Induction by Node Is Mimicked by FGF Signaling
Whole-mount in situ hybridization with Pyst1 probe (purple/blue). (A and B) The node induces ectopic Pyst1 in extra-embryonic epiblast. (A)
Chick donor node (DN) strongly induces ectopic Pyst1. (B) TS through chick DN (asterisk) in (A). (C and D) FGF mimics ability of node to
induce Pyst1. (C) FGF4 bead after 4 hr. (D) FGF8 bead after 2 hr. (E) PBS beads do not induce Pyst1. (F) Exposure to FGF4 (black asterisks)
and FGFR inhibitor SU5402 (red asterisk) after 4 hr inhibits ectopic induction of Pyst1 (compare with contralateral FGF4 bead) and reduces
endogenous Pyst1 expression in neural plate (broken black line indicates normal edge of neural plate).
binding profile [30], does not induce Pyst1 in extra- loss of Pyst1 expression is associated with increased
cell death in distal mesoderm, reduced Fgf8 expressionembryonic epiblast (2 hr, n  4; 4 hr, n  8; data not
shown). These findings indicate that FGF signaling via in the apical ridge, and noticeable stunting of the limb
bud (n  34).a subset of FGFRs can mimic the node’s ability to induce
Pyst1. FGFs can also induce ectopic Pyst1 expression in
regions of the limb where Pyst1 is no longer expressedThe requirement for FGF signaling for ectopic Pyst1
expression in extra-embryonic epiblast was tested by and in interlimb regions. FGF4 or FGF8 beads placed in
proximal mesoderm of older (HH24) limb buds rapidlygrafting a bead soaked in the specific FGFR inhibitor
SU5402 [31], alongside an FGF4 bead. In most cases, induce Pyst1 locally, followed by expansion of Pyst1
expression throughout the mesoderm (n  4, weak ex-SU5402 locally reduces or abolishes Pyst1 induction (9/
12 cases, 2 hr; 5/5 cases, 4 hr; Figure 2F), while in all pression after 15 min; n  4, stronger expression after
30 min; n  18, very strong expression 2 hr and 3 hr;cases (n  9), control DMSO beads have no effect. In
five embryos, in which SU5402 beads became displaced compare Figure 3H with control PBS bead, 3I). Applica-
tion of FGF4 beads to the flank of HH14/15 embryos, atoward host neural plate, endogenous Pyst1 expression
is also reduced (Figure 2F). This indicates that, as for procedure previously shown to initiate limb develop-
ment [32], induces ectopic Pyst1 expression within 2 hrother preneural genes [21], FGF signaling is required for
Pyst1 induction and for its maintenance in the neural in flank lateral plate mesoderm and adjacent somites
(n  2). After 24 hr, induced Pyst1 expression is moreplate.
Striking parallels can be drawn with respect to the robust and expands into the ectopic limb buds (Figure
3J; 9/15 cases). Thus, as in the neural induction assay,control of Pyst1 expression in developing limbs. Re-
moval of the apical ridge from early limb buds reduces expression of Pyst1 in limb bud mesoderm and flank is
an early response to application of either FGF4 or FGF8.endogenous Pyst1 expression within an hour (data not
shown). Three hours after ridge removal, Pyst1 expres- Signaling via FGF receptors can stimulate a number
of downstream pathways including the Ras/MAPK cas-sion which normally extends throughout the limb bud
mesoderm is lost completely (3/4 cases, 3 hr; 4/4 cases, cade [33]. As Pyst1 specifically dephosphorylates and
inactivates MAPK [16, 34], we speculated that Pyst124 hr; compare Figures 3A and 3B), and a small amount
of cell death can be detected at the tip by Nile Blue expression might in turn be regulated via the Ras/MAPK
pathway. To investigate this possibility, Pyst1 expres-Sulfate staining (compare Figures 3C, 3C, 3D, and 3D;
n  18). Furthermore, FGF4 beads placed in distal limb sion was examined in embryos following exposure to the
specific MAPK kinase (MKK) inhibitor PD184352 [35, 36].mesoderm immediately after ridge removal maintained
Pyst1 expression (4/4 cases, 2 hr; 6/6 cases, 10 hr; In the neural induction assay, beads soaked in
PD184352 or DMSO only were grafted together with aFigure 3E), while PBS beads had no effect (n 12; Figure
3F). Exposure to beads soaked in the FGFR inhibitor HH3 node into the extra-embryonic epiblast and Pyst1
expression assessed after 4 hr. Pyst1 is induced in onlySU5402 (0.5 mM) also abolishes Pyst1 expression after
3 hr (4/4 cases; compare Figure 3G with 3G). Under 2/7 cases when the node is exposed to PD184352, in
comparison with control DMSO beads (Figure 4A; 7/7these conditions, little cell death can be detected (Figure
3G″; n  8) and Fgf8 is expressed normally in the apical cases). FGF4-induced Pyst1 is also reduced or absent
in the vicinity of PD184352 beads (2 hr, 2/2 cases; 4ridge (compare Supplemental Figures S3A, S3A, and
S3A″; n  2). With beads soaked in higher concentra- hr, 13/14 cases), while contralateral FGF4 beads alone
induce high-level Pyst1 (n 16; Figure 4B). Furthermore,tions of SU5402 placed in the endogenous Pyst1 domain
at the tip of the limb bud, and/or at longer time points, in three cases where the inhibitor bead was displaced
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Figure 3. Endogenous Pyst1 Expression in
the Limb Is Maintained by FGF Signaling in
the Apical Ridge
(A) Endogenous Pyst1 expression in control
limb bud at HH22. (B) Loss of Pyst1 expres-
sion 24 hr following apical ectodermal ridge
removal (-AER; broken red line). (C and C)
Detection of cell death by Nile blue sulfate
(NBS) staining in a control untreated HH22
limb bud. A high level of apoptosis normally
occurs in apical ridge cells. (D and D) Apo-
ptosis 6 hr following apical ridge removal
(broken black line) is confined to scattered
cells in limb tip. (E) Maintenance of Pyst1 ex-
pression by an FGF4 bead (asterisk) 10 hr
following ridge removal (broken red line). (F)
PBS control bead (asterisk) does not maintain
Pyst1 after ridge removal (broken black line).
(G, G, and G″) Complete loss of Pyst1 ex-
pression following treatment with SU5402
bead. (G) Endogenous Pyst1 expression in
contralateral untreated limb at HH21. (G)
Limb treated with bead soaked in 0.5 mM
SU5402 bead (asterisk) for 3 hr. (G″) Same
limb as in (G) stained for cell death with NBS.
(H) Ectopic Pyst1 expression (arrowhead) 3
hr after an FGF4 bead (asterisk) was placed
proximally in HH24 limb bud. (I) PBS control
bead (asterisk) does not expand distal endog-
enous Pyst1 expression. (J) Dorsal view.
FGF4 bead implanted in flank of HH15 em-
bryo for 24 hr. Pyst1 expression in ectopic
limb bud (arrowhead). El, ectopic limb bud;
fl, wing bud; hl, leg bud.
toward the host neural plate, endogenous Pyst1 expres- (n  3; data not shown) or after 20 hr in the limb (Figure
4G; 17/19 cases). Thus, although signaling through PI3sion is also inhibited (Figure 4B). Coimplantation of
PD184352 and FGF8 beads in the limb also locally inhib- kinase may be driven by application of FGF on beads,
this pathway does not contribute to the regulation ofits ectopic Pyst1 expression (2 hr and 3 hr, n  8; Figure
4C). When PD184352 beads were placed at the tip of endogenous Pyst1 expression.
Although many growth factors signal through the Ras/the limb bud where Pyst1 is expressed at very high
levels, expression decreases dramatically in the poste- MAPK pathway, several have recently also been shown
to activate the p38/MAPK pathway (e.g., [39–42]). Torior region, and outgrowth of the limb bud is markedly
reduced leading to an indented shape (8/10 cases; Fig- determine if p38 MAPK activation participates in Pyst1
induction by FGF, we implanted beads soaked inure 4D), but expression in the anterior region is relatively
unaffected. These results strongly suggest involvement SB203580, a specific inhibitor of p38/MAPK, [43] into
the limb bud. In contrast to the marked reduction inof the Ras/MAPK pathway in regulation of Pyst1 by FGFs
in both neural plate and posterior limb mesoderm. Pyst1 expression when PD184352 is applied, SB203580
has no effect (compare Figure 4H with control DMSOFGF can also signal through the PI3 kinase pathway
(e.g., [37]). To determine whether this pathway contrib- bead in 4I; n  10 at 24 hr). In Drosophila, expression of
optomotor blind (omb), downstream of decapentaplegicutes to Pyst1 induction, we coimplanted a bead soaked
in FGF8 or FGF4 with a bead soaked in a PI3K-specific (dpp), is inhibited by SB203580 [44]. In the chick limb
bud, anterior expression of Tbx3, an ortholog of omb,inhibitor [38], LY294002, into the extra-embryonic epi-
blast or the proximal developing limb. LY294002 beads is downstream of Bmp, an ortholog of dpp [45], and
SB203580 inhibits Tbx3 expression (5/8 cases, 20–24slightly reduce the ability of FGF4 to induce ectopic
Pyst1 in the neural induction assay (4/6 cases; Figure hr; control DMSO beads showed no effect, n  2; see
Supplemental Figures S4A and S4B). Thus, Pyst1 ex-4E) in comparison with control DMSO beads which do
not affect Pyst1 expression (n  5; data not shown). pression is not regulated via the p38/MAPK pathway.
These findings show that inhibition of MAPK signalingSimilarly, in the limb, LY294002 locally inhibits Pyst1
induction by FGF8 at 4 hr (n  5; Figure 4F). It should reduces Pyst1 expression and interferes with limb bud
outgrowth. Pyst1 specifically inactivates MAPK, sug-be noted that in this experiment, we applied FGF8,
whereas in PD184352 inhibitor experiments in the limb, gesting that Pyst1 may itself be a crucial component
of a negative feedback loop governing levels of MAPKFGF4 was used. We also implanted LY294002 beads to
the tip of developing limb buds or into the neural plate signaling downstream of FGF receptors in vivo. In order
to test the role of Pyst1 in embryonic development, weto look at the effects on endogenous Pyst1 levels. How-
ever, in this experiment, no change in Pyst1 expression overexpressed Pyst1 as an EGFP fusion protein and
examined MAPK activity on a cell by cell basis in neuralis detected in the neural plate after 6 hr with LY294002
FGF Signaling and Pyst1/MKP3
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Figure 4. Inhibiting MAPK Signaling Blocks Pyst1 Expression
(A–D) Beads soaked in MAPK kinase-specific inhibitor, PD184352. (A) Neural induction assay. Ectopic induction of Pyst1 expression by node
(yellow asterisks) is blocked by PD184352 (left; red asterisk), while DMSO control bead (right; white asterisk) has no effect. (B) Four hour
exposure to FGF4 beads (white asterisks) induces Pyst1, but this is inhibited in the presence of PD184352 bead (left; red asterisk; 4 hr).
Blocking signaling via MAPK also downregulates endogenous Pyst1 (broken red line indicates normal edge of neural plate). (C and D) Limb
buds. (C) PD184352 bead (red asterisk) locally inhibits ectopic Pyst1 induction (arrowhead) at 2 hr when coimplanted with FGF4 bead (white
asterisk) in proximal nonexpressing region of HH24 limb buds. (D) PD184352 bead (asterisk) locally inhibits endogenous Pyst1 expression
(arrowhead) in posterior limb bud and produces limb indentation.
(E–G) Beads soaked in the specific PI3 kinase inhibitor, LY294002. (E) LY294002 bead (red asterisk) mildly inhibits ectopic Pyst1 expression
when coimplanted with an FGF4 bead (left; white asterisk) in neural plate compared with Pyst1 induced by FGF4 alone (right; white asterisk).
Note absence of effect on endogenous Pyst1 domain. (F) LY294002 bead (red asterisk) locally inhibits ectopic Pyst1 induction at 3 hr when
coimplanted with FGF8 bead (white asterisk) in proximal nonexpressing region of HH24 limb buds. (G) LY294002 bead (asterisk); no inhibition
of endogenous Pyst1 expression detected at 24 hr. (H and I) Beads soaked in the specific p38/MAPK pathway inhibitor, SB203580. (H)
SB203580 bead (asterisk) does not inhibit Pyst1 expression at 24 hr. (I) DMSO control bead (asterisk) has no effect on Pyst1 expression.
plate and assessed effects on limb bud morphology low levels of active MAPK in nontransfected neural plate
(475/1064 (45%) cells in two embryos). Further, in re-and outgrowth. As a negative control, we used a vector
expressing EGFP alone. We confirmed the ability of the gions where clusters of Pyst1-EGFP-expressing cells
are found, the neural plate is kinked (observed in 48/54Pyst1-EGFP fusion protein to dephosphorylate acti-
vated MAPK in COS cells (Figure 5A). sections in five embryos; Figures 5D–5D″), suggesting
that cells expressing high levels of Pyst1 have differentActivated MAPK is detected in the early neural plate
(Figure 1E), and we first confirmed that it can be acti- proliferative and/or adhesive properties to their neigh-
bors. Thus, as is the case when Pyst1 is expressed in cellvated in this tissue downstream of FGF signaling by
implanting an FGF4 bead and assaying for expression of lines [16], overexpression of Pyst1 in embryos results in
decreased levels of activated MAPK, consistent with theactivated, dual-phosphorylated MAPK. FGF4 increases
levels of activated MAPK in the neural plate (7/8 cases), hypothesis that Pyst1 normally regulates MAPK activity
during embryonic development.while PBS beads have no effect (n  5; Figures 5B
and 5C). The Pyst1-EGFP fusion construct was next These constructs were also electroporated into limb
buds of HH21-22 embryos. 51/63 (81%) of the limbs thatelectroporated into the neural plate and expression of
activated MAPK analyzed after 6 hr. Cell by cell analysis express Pyst1-EGFP after 12–24 hr display abnormal
phenotypes ranging from mild squaring to severe trun-of neural plate transfected with Pyst1-EGFP reveals a
mosaic of EGFP expressing cells most of which have cation (Figure 6A; compare Figure 6B with 6B and 6B″),
and the severity appears to correlate with extent oflow levels of activated MAPK (68/75 (90%) cells in three
embryos; Figures 5D–5D″). In contrast, fewer control Pyst1-EGFP. When empty pEGFP-N1 vector was used,
EGFP expression could be readily detected, and limbcells (expressing EGFP only) have low levels of active
MAPK (68/109 (62%) cells in three embryos; Figures buds were normal in nearly every case and no tip inden-
tations were produced (15/17 cases; compare Figure5E–5E″), and this is similar to the number of cells with
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observed in any of the truncated limb buds in distal
regions of the bud expressing Pyst1-EGFP (compare
untreated limb in Figures 7B and 7C with Pyst1-EGFP
electroporated limb in 7B and 7C). Thus, Pyst1 overex-
pression is not accompanied by cell death.
Discussion
These results place a dual specificity MAPK phospha-
tase in a physiological context in a vertebrate and show
that Pyst1 expression in neural plate and limb is regu-
lated by FGFs. When tissues expressing FGFs are re-
moved or beads soaked in the FGFR inhibitor, SU5402,
are applied, Pyst1 expression is abolished. We have
shown in the limb that this change in Pyst1 expression
cannot be accounted for by cell death. Application of
FGFs can maintain endogenous Pyst1 expression in the
limb or can induce it very rapidly in ectopic locations in
both early embryos and limbs, showing that expression
of Pyst1 is an early response to FGF signaling. Further-
more, using specific inhibitors for the classical MAPK
cascade, the PI3 kinase and p38 MAPK pathways, we
show that maintenance of endogenous Pyst1 expres-
sion in the neural plate and posterior limb mesoderm
by FGF occurs by a direct feedback loop involving the
classical pathway. Although PD184352 inhibits Pyst1 in
neural plate and posterior limb, unexpectedly, anterior
limb Pyst1 expression is relatively unaffected. It may be
significant that different Fgfs are known to be expressed
in anterior and posterior apical ridge (reviewed in [1]).
Overexpression of Pyst1 causes limb bud truncations
and defects in neural plate development, suggesting
that FGF-inducible expression of Pyst1 is critical in
maintaining appropriate levels of signaling through the
Ras/MAPK cascade. In the neural plate, Pyst1 behaves
like a preneural gene and its dependence on MAPK
signaling downstream of node/FGF signaling suggests
that this pathway regulates the onset of neural develop-
ment in higher vertebrates, as observed in invertebrateFigure 5. Overexpression of Pyst1 Decreases Levels of Activated
(ascidian) embryos [46, 47]. Furthermore, later differenti-MAPK in Neural Plate
ation of the neural plate is also dependent on MAPK(A) EGFP-tagged Pyst1 dephosphorylates ERK in Cos1 cells. (B)
signaling since preliminary results show that PD184352FGF4, but not (C) PBS beads (asterisks) locally increase levels of
activated MAPK (detected with anti-dual-phosphorylated MAPK an- beads inhibit expression of the later neural marker Sox2
tibody, brown labeling) in the neural plate. (D and E) Levels of acti- (S.L. and K.S., data not shown). Thus, Pyst1 activity is
vated MAPK following electroporation. (D–D″) Cells expressing likely to be a key regulator of neural induction in the
Pyst1-EGFP (green) and activated MAPK (brown) were scored in TS
chick. In the limb, truncations produced by treatment(red arrowheads, Pyst1-EGFP cells with low activated MAPK). Kinks
with a specific MAPK inhibitor and by overexpressionin neural plate are associated with groups of Pyst1-EGFP-express-
of Pyst1 demonstrate that FGF signaling mediates limbing cells (arrow). (E–E″) Control cells in the neural plate expressing
EGFP have low (red arrowheads) or high (black and white arrow- bud outgrowth via the MAPK pathway. In regions of the
heads) levels of activated MAPK. Scale bars, 25 m. limb in which ectopic Pyst1 was expressed, there was
little cell death, although the normal zones of pro-
grammed cell death were expanded.
The role of Pyst1 in determining precise levels of6C with 6C and 6C″). Thus, overexpression of Pyst1 in
limb buds can inhibit outgrowth and mimics phenotypes MAPK activity in vertebrate embryos is reminiscent of
that of the puckered phosphatase in determining theelicited by ridge removal or pharmacological inhibition
of FGF or Ras/MAPK signaling. Eight limb buds electro- precise levels of JNK/MAPK activity required to achieve
dorsal closure during Drosophila embryogenesis [48].porated with Pyst1-EGFP were assayed for cell death.
In all cases, normal regions of programmed cell death Our results also underscore the importance of phospha-
tases in regulating developmental outcomes of MAPincluding anterior and posterior necrotic zones and the
medial opaque patch are slightly expanded (Figure 7A). kinase signaling. Other intracellular antagonists of FGF
signaling, Sprouty, Sef, and Spred, have been identifiedAn increase in cell death in the opaque patch is most
common (7/8 cases), while no significant cell death is [6–10] (Figure 8). Overexpression of Sprouty, which in
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Figure 6. Overexpression of Pyst1 Inhibits Limb Bud Outgrowth
(A–C) Limb electroporations. (A) Schematic diagrams and percentages of limbs with abnormal phenotypes (n  63). (B, B, and B″) Overexpres-
sion of Pyst1-EGFP fusion construct. (B) Normal untreated (left) limb at HH25/26 (broken red line marks limb outline). (B) Treated (right) limb
bud 24 hr after electroporation showing resulting limb truncation (broken red line). (B″) Same limb as in (B), viewed under UV, showing
extensive EGFP expression (broken white line marks limb outline). (C, C, andC″) Control experiment. (C) Normal morphology of untreated
(left) limb bud at HH25/26 viewed under brightfield (broken red line marks limb outline; yellow color due to filter). (C) Treated (right) limb bud,
viewed under brightfield, electroporated 24 hr earlier with the pEGFP-N1 vector showing normal morphology. (C″) Same limb as in (C), viewed
under UV, showing extensive EGFP expression (broken white line marks limb outline).
some contexts prevents activation of raf (e.g., [13]) thus limb bud outgrowth and patterning. The models also
suggest that cells expressing high levels of Pyst1 candecreasing the level of MAPK activity, can also lead to
respond proportionally to agonist concentration, andlimb bud truncations [49]. Sprouty and Sef are induced
this would provide a mechanism for cells to interpret anby FGF and belong to the FGF synexpression group [5]
FGF gradient. Another possible outcome of negativeto which we can now add Pyst1. Sprouty and Sef are
feedback loops in a signaling network is an oscillatoryalso known to be regulated via the MAPK cascade and
output which could allow cells to measure time; indeedas Pyst1 regulates MAPK activity directly, Pyst1 could
a clock mechanism has been proposed for proximo-be pivotal in controlling expression of these antagonists
distal patterning of the limb.which act at different levels in the pathway (Figure 8).
However, subsets of this FGF synexpression group op-
Experimental Procedureserate in specific tissues [49] and, for example, chick
neural plate expresses Pyst1 but not Sprouty2, which is PCR Cloning of Chicken Pyst1
detected in the primitive streak [50]. These intracellular Three overlapping ESTs (GenBank accession numbers BU235949,
controls might not only integrate different intracellular BU250216, and BM490647) were identified by database searching
using the human Pyst1 sequence and used to generate a contiguoustransduction pathways downstream of FGF signaling
sequence assembly corresponding to the full open reading frame[14], but also coordinate inputs from other signaling
of chicken Pyst1. A cDNA fragment corresponding to nucleotidespathways. 772–1149 of this cDNA was then obtained by RT-PCR using total
Recent mathematical modeling of protein kinase sig- RNA isolated from HH16-24 chick embryos as template and the
nal transduction has provided insights into possible following oligonucleotide primers 5-CTGGATCCAAATCCCCATCT
CGGATCACTGG-3 and 5-CCTCGAGTCTCGTAGATTGCAGAGways in which cells in the embryo may respond to FGF
AGTCC-3. Following capture of the resulting PCR product insignaling. These models stress the importance of pro-
pCRBlunt (Invitrogen), this was excised as an EcoRI-XhoI fragmenttein phosphatases in control of timing and duration of
and subcloned into pBSSK (Stratagene).
MAPK signaling and how interpretation of agonist sig-
naling can change over time [51, 52]. They predict that Whole-Mount In Situ Hybridization
Chick embryos were staged according to Eyal-Giladi and Hamiltonthe initial activation of MAPK in response to activation
and Hamburger, and in situ hybridization was carried out usingof tyrosine kinase receptors is “switch-like,” while sus-
standard techniques.tained activation and engagement of feedback loops
leads to different responses. This could provide a mech- Immunocytochemistry
anism for linking different cellular activities which occur Standard whole-mount immunocytochemistry was used to detect
quail cells with QCPN (DS Hybridoma Bank) (1:5). To reveal activatedover different time scales, for example, coordination of
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Figure 7. Cell Death following Overexpres-
sion of Pyst1
(A–C) Overexpression of Pyst1-EGFP fusion
construct. (A) Schematic diagrams of limb
buds with normal and abnormal patterns of
programmed cell death (n  8). (B and B)
Pyst1-EGFP overexpression. (B) Normal mor-
phology of untreated (left) limb bud at HH24/
25 viewed under brightfield (broken black line
marking outline of limb bud). (B) Treated
(right) limb bud showing extensive EGFP ex-
pression (false green color; broken black line
marking limb outline), electroporated 14 hr
earlier with the Pyst1-EGFP fusion construct.
(C and C) Cell death assay. (C) Normal un-
treated (left) limb at HH24/25, same limb as
in (B), stained with NBS showing normal re-
gions of programmed cell death including an-
terior (ANZ) and posterior necrotic zones
(PNZ) and medial opaque patch (OP). (C)
Treated (right) limb bud 14 hr after Pyst1-
EGFP overexpression with resulting limb
truncation (same limb as in [B]; broken yellow
line marking outline of limb) stained with NBS
showing slight expansion of OP and ANZ (ar-
rowheads).
MAPK, rapid fixation in 4% PFA was required, followed by dehydra- PBS (on ice) for 15 min at 4C, photographed, then fixed in 4% PFA/
PBS for subsequent in situ hybridization.tion to MeOH and rehydration. Embryos were incubated serially with
intervening washes in activated MAPK antibody (raised in rabbit)
(1:50) (Cell Signaling Technology), biotinylated anti-rabbit antibody Plasmid Constructs
(1:1000) (Jackson), and StreptAvidin-HRP conjugate (1:50) (Becton To express wild-type human Pyst1 as an NH2-terminal fusion to
Dickinson) and then underwent a standard DAB reaction. Levels of EGFP, the open reading frame was amplified by PCR using the
active MAPK were scored on a cell by cell basis in 20 m transverse primers 5-CCCAAGCTTATGATAGATACGCTCAGACCCGTGCCCT
sections. TCG -3 and 5-CGCGTCGACGTAGATTGCAGAGAGTCCACCTGGT
ATAC-3 and subcloned into the mammalian expression vector
pEGFP-N1 (Clontech) as a Hind III-Sal I fragment.Tissue Manipulations
Removal of the apical ridge was carried out at HH20 with sharpened
tungsten needles. Nodes were grafted in contact with the extra- Cos Cell Transfection and Western Blots
embryonic epiblast, see [29]. Cos1 cells were cotransfected with 2 g pECE-p44MAPK-HA (a
kind gift from Dr. Anne Brunet) and increasing amounts (0, 0.5, or
2 g) of pEGFP-N1-PYST1 using the calcium phosphate method.Bead Implantations
Heparin beads (Sigma H-5263) were incubated in FGF4, FGF8, or After 48 hr, cells were serum starved for 18 hr and either left un-
treated or stimulated by addition of foetal bovine serum (15% v/vFGF7 (R&D systems) (1 mg/ml in the limb; 50 g/ml in the early
embryo) for 1 hr at RT. PBS soaked beads were used as controls. final concentration) for 15 min. Cells were lysed and 5 g of cell
lysate per transfection analyzed by SDS-PAGE. Levels of HA-taggedAG-1 X2 (BioRad Laboratories) formate-derivitized beads were incu-
bated in one of the following inhibitors: 0.5–10 mM (unless stated p44MAPK, Pyst1-EGFP, and phosphorylated MAPK were deter-
mined by Western blotting using antibodies against HA (12CA5,otherwise) SU5402, 20 mM PD184352, 20 mM LY294002, and10 mM
SB203580 (kind gifts from Sir Philip Cohen) for 1hr at RT. DMSO Cancer Research UK), EGFP (sc-8334, Santa Cruz), or phosphory-
lated MAPK (#9101S, Cell Signaling Technologies), respectively.beads were used as controls. Beads were implanted in the limb and
interlimb regions or in contact with the extra-embryonic epiblast.
In Vivo Electroporation
Pyst1-EGFP fusion DNA construct or empty pEGFP-N1 (Clontech)Nile Blue Staining
Nile Blue staining on whole embryo limbs was performed essentially vector was electroporated into HH21-22 chick wing bud or into
HH3 neural plate. For limb, multiple injections of plasmid (1–3 g/as described in [53]. Briefly, embryos were dissected in PBS and
immediately incubated in a 1:5000 solution of Nile Blue A (Sigma) l, 1:40 (v/v) 0.4% fast green/distilled H2O) were made into mesen-
chyme. Electroporation was then carried out using two electrodesin PBS for 15–20 min at 37C. Embryos were then rinsed in cold
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